Strumento inattivo

Altre lingue BIO-TECHNE Corp Nasdaq

Azioni

US8783771004

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

11/06	Transcript : Bio-Techne Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 09:20 AM
06/06	Transcript : Bio-Techne Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:30 AM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES	03/06
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MAURICEFLEX SYSTEM AT THE ANNUAL ASMS CONFERENCE	31/05
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES	31/05
BIO-TECHNE CORPORATION - SCALEREADY ANNOUNCES $20 MILLION G-REX GRANT PROGRAM FOR THE ADVANCEMENT OF CELL AND GENE THERAPY DEVELOPMENT AND MANUFACTURING	30/05
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE	30/05
Bio-Techne Corporation to Showcase Multiple Applications of the MauriceFlex?? System at the Annual ASMS Conference	30/05
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing	29/05
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE	23/05
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY	22/05
Bio-Techne Corporation and Regulus Therapeutics Inc. Announces Continued Technical and Clinical Collaboration	22/05
Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing	16/05
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024	08/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Top Midday Gainers	01/05
US Equity Indexes Mixed as Investors Look for Clarity in Fed's Policy Path in Presidential Election Year	01/05
US Equity Indexes Mixed Ahead of Fed Policy Statement, Views on Monetary Policy Path for 2024	01/05
Bio-Techne Shares Jump After Fiscal Q3 Beat	01/05
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	01/05
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	01/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BIO-TECHNE Corp Nasdaq

Azioni

US8783771004

Altre lingue

Filtri